The most effective way to drive change in healthcare is to focus on what remains constant: serving patients.

In this episode, sponsored by Amgen. Leandro Boer, Vice President of US Medical and General Medicines at Amgen, discusses how the company is reimagining care delivery to enhance access and outcomes, particularly for underserved populations. He explains how precision medicine, multi-omics, and advanced data use are driving innovation and preventing “data waste,” while Amgen invests heavily in R&D, including a $600 million Innovation and Discovery Science Center. Leandro highlights the role of technology in accelerating clinical trials through machine learning and anticipates three major shifts within the next five years: faster drug development, reduced administrative burden through the use of AI, and improved patient identification via care pathway automation. He also highlights Amgen’s goal to reduce cardiovascular events by 50% by 2030, the importance of diverse clinical representation through the RISE initiative, and the company’s commitment to employee well-being as the foundation for improved patient care.

Tune in and learn how innovation, equity, and purpose-driven leadership are transforming the future of healthcare!

Resources:

Connect with and follow Leandro Boer on LinkedIn.
Follow Amgen on LinkedIn and explore their website.

Eliminating Data Waste: How Amgen’s Leandro Boer Is Reimagining Precision Medicine and Patient Equity